The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: Insights from genetic models of hormone and hormone receptor deficiency

Endocrine Reviews

Volumn 21, Issue 3, 2000, Pages 292-312

  Dorshkind, Kenneth ^a   Horseman, Nelson D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HORMONE RECEPTOR; PROLACTIN; SOMATOMEDIN C; THYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC DISORDER; GENETIC MODEL; IMMUNE SYSTEM; IMMUNITY; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE FUNCTION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; HUMAN GROWTH HORMONE; HUMANS; IMMUNITY; INSULIN-LIKE GROWTH FACTOR I; LYMPHOCYTES; MICE; MICE, MUTANT STRAINS; PROLACTIN; THYROID HORMONES;

EID: 0034454903     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.21.3.292     Document Type: Review

References (265)

1. The effect of hypophysectomy upon the involution of the thymus in the rat
2. Mouse thymus in hereditary pituitary dwarfism
3. Thymus, peripheral lymphoid tissues and immunological responsiveness of the pituitary dwarf mouse
4. Age dependency of the primary immune response in the hereditary pituitary dwarf and normal Snell/Bagg mouse
5. Pituitary and serum concentrations of prolactin and GH in Snell dwarf mice
6. A study of some cytochemical reactions and of the hormone content of the adenohypophysis in normal and in genetic dwarf mice
7. Analysis of growth hormone genes in mice with genetic defects of growth hormone expression
8. Regulation of immunity in rats by lactogenic and growth hormones
9. Regulation of humoral immunity in rats by pituitary hormones
10. Immunodeficiency in hypophysectomized rats
11. Action of hypophysectomy on antibody formation in the rat
12. Immunobiology
13. Growth hormone in immune reconstitution
14. Use of neuroendocrine hormones to promote reconstitution after bone marrow transplantation
15. Effects of growth hormone and prolactin on immune development and function
16. The somatogenic hormones and insulin-like growth factor-I: Stimulators of lymphopoiesis and immune function
17. Immune-neuro-endocrine interactions: Facts and hypotheses
18. Prolactin, growth hormone, and insulin-like growth factor-I in the immune system
19. Molecular actions of prolactin in the immune system
20. Role of prolactin and growth hormone on thymus physiology
21. Effects of growth hormone and insulin-like growth factor I on the immune system
22. Action of pituitary and lymphocyte prolactin
23. Growth hormone, prolactin, and insulin-like growth factors: New jobs for old players
24. Prolactin and growth hormone in the regulation of the immune system
25. Experimental basis for neural-immune interactions
26. Sex hormones as negative regulators of lymphopoiesis
27. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action
28. Neuroendocrine-immune system interactions and autoimmunity
29. Dwarf: A new Mendelian recessive character of the house mouse
30. Dwarf locus mutants lacking three pituitary cell types result from mutations in the pou-domain gene pit-1
31. Pituitary lineage determination by the prophet of pit-1 homeodomain factor defective in Ames dwarfism
32. Generation and regeneration of cells of the B-lymphocyte lineage
33. B cell development in the bone marrow
34. B cell development
35. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow
36. Early T lymphocyte progenitors
37. Cellular interactions in thymocyte development
38. Regulation of hemopoiesis by bone marrow stromal cells and their products
39. Cells and molecules that regulate B lymphopoiesis in bone marrow
40. T-cell differentiation is influenced by thymic microenvironments
41. The thymic microenvironment
42. Immunologic and hematologic effects of neuroendocrine hormones. Studies on dw/j dwarf mice
43. Defective B cell development in Snell dwarf (dw/dw) mice can be corrected by thyroxine treatment
44. Primary B cell development is impaired in mice with defects of the pituitary/thyroid axis
45. Pituitary dependence of bone marrow function
46. Effects of hormones on development and function of lymphoid tissues. Synergistic action of thyroxin and somatotropic hormone in pituitary dwarf mice
47. Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo
48. T and B lymphocytes in pituitary dwarf Snell-Bagg mice
49. Immunological competence in Snell-Bagg pituitary dwarf mice: Response to the contact-sensitizing agent oxazolone
50. The complexity of signaling pathways activated by the BCR
51. Hormones and the immunological capacity. II. Reconstitution of antibody production in hormonally deficient mice by somatotropic hormone, thyrotropic hormones and thyroxin
52. Hormones and the immunological capacity. IV. Restorative effects of developmental hormones or of lymphocytes on the immunodeficiency syndrome of the dwarf mouse
53. Delayed hypersensitivity in the hereditary pituitary dwarf Snell-Bagg mouse
54. Effect of hypophysectomy on immunological recovery after sublethal irradiation of adult rats
55. Hormones and the immunological capacity. III. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse
56. Immunodeficiency of the thymus-dependent system of the Ames dwarf mouse
57. Humoral and cell-mediated immunity in mice with genetic deficiencies of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones
58. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo
59. T-lymphocyte differentiation and biology, ed 4
60. Innate vs. acquired immunity in listeriosis
61. Innate immunity: Impact on the adaptive immune response
62. Macrophage receptors and innate immunity
63. The pituitary gland is required for protection against lethal effects of Salmonella typhimurium
64. Prolactin protection against lethal effects of Salmonella typhimurium
65. Ectopic pituitary transplants restore immunocompetence in Ames dwarf mice
66. Immunologic disparity in the hypopituitary dwarf mouse
67. Prevention of immunologic deficiency in pituitary dwarf mice by prolonged nursing
68. Dwarf mice and the ageing process
69. Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
70. Inhibition of lymphocyte proliferation by antibodies to prolactin
71. Drug therapy: Bromocriptine
72. Influence of bromocriptine administration to mothers on the development of pup thymocyte and splenocyte subsets and on mitogen-induced proliferation in the mouse
73. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine
74. Immunomodulation by bromocriptine
75. Effect of neonatal milk-prolactin deprivation on the ontogeny of the immune system of the rat
76. Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma
77. Prolactin increases CD4/CD8 cell ratio in thymus grafted congenitally athymic nude mice
78. Neonatal administration of prolactin antiserum alters the developmental pattern of T- and B-lymphocytes in the thymus and spleen of BALB/c female mice
79. Immunosupressive activity of bromocriptine on human T lymphocyte function in vitro
80. Immunosuppressive properties of bromocriptine on human B lymphocyte function in vitro
81. Dopamine receptor mRNAs in the rat lymphocytes
82. Suppression of macrophage activation and lymphocyte function in hypoprolactinemic mice
83. Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion
84. Jak2 is essential for signaling through a variety of cytokine receptors
85. Jak2 deficiency defines an essential developmental check-point in definitive hematopoiesis
86. Stat5a and stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
87. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse
88. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene
89. Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland
90. Expression of short and long forms of prolactin receptor in murine lymphoid tissues
91. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations
92. Growth hormone (GH) and prolactin receptors in human peripheral blood mononuclear cells: Relation with age and GH-binding protein
93. Prolactin receptor expression during adipocyte differentiation of bone marrow stroma
94. Identification and functional activity of prolactin receptors in thymic epithelial cells
95. Pituitary hormones modulate cell-cell interactions between thymocytes and thymic epithelial cells
96. Aging and immune function
97. Immune system development and function in prolactin receptor deficient mice
98. Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse
99. Prolactin binding sites in human erythrocytes and lymphocytes
100. Prolactin receptor gene expression in lymphoid cells
101. Expression of prolactin and its receptor in human lymphoid cells
102. Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin binding by cyclosporine
103. Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line
104. Prolactin receptor gene expression in rat splenocytes and thymocytes from birth to adulthood
105. Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas
106. Thymic origin of the prolactin-dependent Nb2 lymphoma cell line
107. Evolution of lactogen receptors in selected rabbit tissues during pregnancy
108. Early activation of thyrotropinreleasing hormone and prolactin plays a critical role during a T cell-dependent immune response
109. Prolactin receptors on large granular lymphocytes: Dual regulation by cyclosporin A
110. Prolactin receptor expression by rat NK cells
111. Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B, and NK lymphocytes
112. Reduced number of natural killer cells in patients with pathological hyperprolactinemia
113. Natural killer activity in hyperprolactinemic patients
114. Endocrine, paracrine and autocrine actions of prolactin on immune cells
115. Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cell mitogenesis by prolactin
116. Mitogenic effect of prolactin on chicken lymphocytes in vitro
117. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes
118. Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin
119. Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosupression by azidothymidine
120. The physiology and mechanisms of the stress-induced changes in prolactin secretion in the rat
121. Prolactin receptor signal transduction in cells of the immune system
122. Effects of controllable vs. uncontrollable chronic stress on stress-responsive plasma hormones
123. Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis
124. Prolactin: A novel and safe immunomodulating hormone for the treatment of immunodepression following severe hemorrhage
125. Differential effects of growth hormone and prolactm on murine T cell development and function
126. Phenotypic and functional abnormalities of T lymphocytes in pathological hyperprolactinemia
127. The role of prolactin in autoimmune demyelination: Suppression of experimental allergic encephalomyelitis by bromocriptine
128. Prolactin, immunoregulation, and autoimmune diseases
129. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: Possible hormonal stimulation of an autoimmune disease
130. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
131. Regulation of apoptosis by steroid hormones
132. Regulation of cytokine and cytokine receptor expression by glucocorticoids
133. Functional interactions between Stat5 and the glucorticoid receptor
134. Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription
135. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat-5 mediated suppression of the glucocorticoid response
136. Glucocorticoid-prolactin interactions in Nb2 lymphoma cells: Antiproliferative vs. anticytolytic effects
137. Comparison of glucocorticoid-induced effects in prolactin-dependent and autonomous rat Nb2 lymphoma cells
138. Prolacin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression
139. Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells
140. Tissue distribution and regulation of rat prolactin receptor gene expression. Quantitative analysis by polymerase chain reaction
141. The somatomedin hypothesis revisited: Differential effects of growth hormone and IGF-I on skeletal growth of the rat in vivo
142. Structural features of prolactins and growth hormones that can be related to their biological properties
143. Inherited ateliotic dwarfism in mice; characeristics of the mutation, little on chromosome 6
144. Growth hormone deficiency in "little" mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2,-1 or -4
145. Regulation of metabolic water and protein compartments by insulin-like growth factor-I and testosterone in growth hormone-deficient lit/lit mice
146. Molecular basis of the little mouse phenotype and implications for cell type-specific growth
147. Stimulation of growth in the little mouse
148. Production of immunoreactive growth hormone by mononuclear leukocytes
149. Immunoreactive growth hormone (GH) secretion by human lymphocytes: Augmented release by exogenous GH
150. Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay
151. Immunoreactive growth hormone production by cultured lymphocytes
152. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)
153. IGF-I is required for normal embryonic growth in mice
154. Role of insulin-like growth factors in embryonic and postnatal growth
155. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (IGF1r)
156. Growth hormone and its receptor are expressed in human thymic cells
157. Expression of growth hormone receptors in murine lymphoid cells analyzed by flow cytofluorometry
158. Functional receptors for insulin-like growth factors I and II in rat thymocytes and mouse thyoma cells
159. Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice
160. Type I insulin-like growth factor receptor expression in different developmental stages of human thymocytes
161. Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes
162. The production of growth hormone by subpopulations of rat mononuclear leukocytes
163. Immunohistochemical localization of insulin-like growth factor 1 in the adult rat
164. Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily
165. The transcription factor Pit-1/GHF-1 is exprssed in hemopoietic and lymphoid tissues
166. Insulin-like growth factor-1 regulates pro-B cell differentiation
167. Secretion of insulinlike growth factor I and insulinlike growth factor-binding proteins by murine bone marrow stromal cells
168. Specific binding sites for growth hormone in cultured mouse thymic epithelial cells
169. Control of the thymic microenvironment by growth hormone/insulin-like growth factor-I mediated circuits
170. The indirect participation of growth hormone in the thymocyte proliferation system
171. Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochorome flow cytometry
172. Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells
173. Insulin-like growth factor-1 binds selectively to human peripheral blood monocytes and B-lymphocytes
174. The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes
175. Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone
176. Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells
177. Hormones, lymphohemopoietic cytokines and the neuroimmune axis
178. In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation
179. Insulin-like growth factor-1 potentiates expansion of interleukin-7 dependent pro-B cells
180. Insulin-like growth factor-1 stimulation of lymphopoiesis
181. Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells
182. Comparative studies of the granulopoietic enhancing effects of biosynthetic human insulin-like growth factors I and II
183. Phosphatidylinositol 3′-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors
184. 2
185. A newly defined property of somatotropin: Priming of macrophages for production of superoxide anion
186. Human insulin-like growth factor I exerts hematopoietic growth-promoting effects after in vivo administration
187. Enhancement of thymic recovery after cyclosporine by re combinant human growth hormone and insulin-like growth factor 1
188. Repopulation of the atrophied thymus in diabetic rats by insulinlike growth factor 1
189. Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice
190. The aging immune system: Primer and prospectus
191. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys
192. Neuroendocrinology and aging
193. Human growth hormone and human aging
194. The regulation and mechanisms of action of growth hormone and insulin-like growth factor I during normal ageing
195. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-1 levels in old men
196. The endocrinology of aging
197. Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow
198. Effect of bovine growth hormone administration on the pattern of thymic involution in mice
199. 3 pituitary adenoma cells can reverse thymic aging in rats
200. Pituitary epithelial cell implants reverse the accumulation of CD4-CD8-lymphocytes in thymus glands of aged rats
201. Aging in the T lymphocyte compartment. A developmental view
202. Thymocyte progenitors in ageing
203. Age-related changes in the capacity of bone marrow cells to differentiate in thymic organ cultures
204. Quantitative analysis of bone marrow thymic progenitors in young and aged mice
205. Age-related decrease in mouse T cell progenitors
206. Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment
207. Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphoma
208. Effects of human growth hormone in men over 60 years old
209. Pituitary-thyroid axis and immune system: A reciprocal neuroendocrine-immune interaction
210. Inherited primary hypothyroidism in mice
211. Evaluation and characterization of the hypothyroid hyt/hyt mouse I. Somatic and behavioral studies
212. Biology of the congenitally hypothyroid hyt/hyt mouse
213. Identification of a point mutation in the thyrotropoin receptor of the hyt/hyt hypothyroid mouse
214. The thyrotropin (TSH) receptor transmembrane domain mutation (Pro 556-Leu) in the hypothyroid hyt/hyt mouse results in plasma membrane targeting but defective TSH binding
215. Thyroid hormone receptors: Multiple forms, multiple possibilities
216. Thyroid hormone receptor gene knockouts
217. Abnormal heart rate and body temperature in mice lacking thryoid hormone receptor α1
218. The T3Rα gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production
219. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor β: Evidence for tissue-specific modulation of receptor function
220. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation
221. Specific binding sites for triiodothyronine in the plasma membrane of rat thymocytes. Correlation with biochemical response
222. Proliferation of bone marrow pro-B cells is dependent on stimulation by the pituitary/thyroid axis
223. Identification of nuclear triiodiothyronine receptors in the thymic epithelium
224. Immune development in young-adult C.RF-hyt mice is affected by congenital and maternal hypothyroidism
225. Effects of T3Rα1 and T3Rα2 thyroid hormone nuclear receptors deletion on T and B lymphocyte development
226. Thyroid hormone receptor coactivators and corepressors
227. Thyroid hormone depletion inhibits astrocytoma proliferation via a p53-independent induction of p21 (WAF1/CIP1)
228. Pleiotropic influence of triiodothyronine on thymus physiology
229. Evidence that an increase in cytoplasmic calcium is the initiating event in certain plasma membrane-mediated responses to 3,4,3′-triiodothyronine in rat thymocytes
230. Thyroid hormone transcriptional regulatory region of the growth hormone gene
231. Immunodepression in thyroid-deprived animals
232. Anterior pituitary gland and lymphoid tissue growth
233. The effect of the thyroidal state on the immunological state of the chicken
234. Immunomodulatory role of thyroid hormones: In vivo effect of thyroid hormones on the blastogenic response to lymphoid tissue
235. Endocrine influences on lymphatic organs, immune responses, inflammation autoimmunity
236. Effect of hypo- and hyperthyroidism on the balance between helper and suppressor T cells in rats
237. Effects of experimental hyper- and hypothyroidism on numbers of blood mononuclear cells and immune function in rats and guinea pigs
238. Antibody regulation in birds by thyroid hormone
239. Effect of thyroxine on the immune response of mice in vivo and in vitro
240. The effect of tri-iodothyronine on the phytohaemagglutinin response of T lymphocytes
241. Influence of thyroxine and thyroxine with growth hormone and prolactin on splenocyte subsets and on the expression of interleukin-2 and prolactin receptors on splenocyte subsets of Snell dwarf mice
242. 3 syndrome
243. Increased immunological efficiency in young mice by short-term treatment with L-thyroxine
244. Effects of thyroxine on T-cell counts and tumor cell rejection in mice
245. Hormones
246. Enhancement of mouse NK cell activity by thyroxine
247. Hyperthyroxinemic mice have reduced natural killer cell activity. Evidence for a defective trigger mechanism
248. Recovery of spleen cell natural killer activity by thryoid hormone treatment in old mice
249. Recovery of age-dependent immunological deterioration in Balb/c mice by short-term treatment with L-thyroxine
250. Modulation of lymphoid cell sensitivity to interferon by thyroid hormones
251. Congenital hypothyroidism and immunodeficiency: Evidence for an endocrine-immune interaction
252. Pleiotropy and redundancy: T cell-derived lymphokines in the immune response
253. Immune responses in interleukin-2-deficient mice
254. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
255. Generation and analysis of interleukin-4-deficient mice
256. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
257. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine
258. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment
259. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β
260. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice
261. The stress concept and neuroimmunoregulation in modern biology
262. Phenotypic and functional analysis of B lymphopoiesis in interleukin-7-transgenic mice: Expansion of pro/pre-B cell number and persistence of B lymphocyte development in lymph nodes and spleen